Search Results - "Dharmanand, Balebail G."

Interstitial pneumonia with autoimmune features by Karjigi, Uma, Dharmanand, Balebail

“…Interstitial pneumonia (IP) or interstitial lung disease (ILD) affect lung parenchyma, and if not treated will lead to irreparable lung damage. Classification…”
Get full text

Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real‐world clinical experience from India by Shobha, Vineeta, Chandrashekara, S., Rao, Vijay, Desai, Anu, Jois, Ramesh, Dharmanand, Balebail G., Kumar, Sharath, Kumar, Pradeep, Dharmapalaiah, Chethana, Mahendranath, Kurugodu Mathada, Prasad, Shiva, Daware, Manisha Ashwin, Singh, Yogesh, Karjigi, Uma, Nagaraj, S., Anupama, K. R.

“…Aim Tuberculosis (TB) is one of the major adverse events of concern associated with the use of biologics for managing autoimmune inflammatory rheumatic…”
Get full text

Approach to a patient with soft tissue rheumatic pain by Dharmanand, Balebail G

“…Abstract Pain arising out of soft tissue structures around the joints (soft tissue rheumatism) may be more common than symptoms arising from joints and bone…”
Get full text

Influence of disease duration and socioeconomic factors on the prevalence of infection and hospitalization in rheumatoid arthritis: KRAC study by Chandrashekara, S., Shobha, Vineeta, Dharmanand, Balebail G., Jois, Ramesh, Kumar, Sharath, Mahendranath, Kurugodu Mathada, Haridas, Vikram, Prasad, Shiva, Singh, Yogesh, Daware, Manisha Ashwin, Swamy, Anupama, Subramanian, Ramaswamy, Somashekar, Srirama Attappa, Shanthappa, Arun Madhanaghatta, Anupama, K. R.

“…Aim The use of healthcare resources by rheumatoid arthritis (RA) patients can be related to the presence of disease, comorbid conditions, use of steroids, and…”
Get full text

Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India by Talari, Keerthi, Ravindran, Vinod, Kumar, Pradip, Patil, Pravin, Mouli, Sarath, Bandyopadhyay, Syamasis, Dharmanand, Balebail, Ray, Abhrajit, Rajeshwari, Shankaralingam, Amin, Sanjiv, Oak, Jyotsna, Chaturvedi, Ved, Malaviya, Anand, Mukherjee, Sukumar

“…Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs,…”
Get full text

Soft tissue rheumatism by Hutson, Michael A, Dharmanand, Balebail G

Get full text

International scleroderma symposium: July 16-17, 2016, Bengaluru by Dudam, Rajkiran, Dharmanand, Balebail

Get full text

Clinical profiling of psoriatic arthritis: an observational cross-sectional study from Karnataka Psoriatic Arthritis Cohort by Kodishala, Chanakya, Shobha, Vineeta, Chandrashekara, S, Kumar, Sharath, Haridas, Vikram, R Rao, Vijay, Jois, Ramesh, Daware, Manisha, Singh, Yogesh, Singhai, Shweta, Dharmanand, B, Chebbi, Pramod, Subramanian, R, Kamath, Ashwini, Karjiigi, Uma, K Jain, Vikram, Dharmapalaiah, Chethana, Prasad, Shiva, Srinivasa, C, Janardana, Ramya, Pinto, Benzeeta, Nazir, Beenish, Harshini, A, Mahendranath, K

“…Background: Clinical patterns and disease activity burden of psoriatic arthritis (PsA) varies in different parts of the world. There are limited studies from…”
Get full text

Survey of current practice of scleroderma management in India by Yathish, G, Jois, Ramesh, Balebail, Dharmanand, Ravindran, Vinod

Get full text